Kymera Therapeutics initiated at Outperform by Raymond James
Raymond James initiated coverage of Kymera Therapeutics with an Outperform rating, according to Benzinga’s ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.